Amarin Corp. PLC ADR (AMRN): Price and Financial Metrics


Amarin Corp. PLC ADR (AMRN): $4.14

-0.10 (-2.36%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

AMRN POWR Grades


  • Value is the dimension where AMRN ranks best; there it ranks ahead of 95.59% of US stocks.
  • The strongest trend for AMRN is in Stability, which has been heading up over the past 31 weeks.
  • AMRN ranks lowest in Momentum; there it ranks in the 5th percentile.

AMRN Stock Summary

  • With a price/earnings ratio of 1,822.68, Amarin Corp Plc P/E ratio is greater than that of about 99.53% of stocks in our set with positive earnings.
  • The ratio of debt to operating expenses for Amarin Corp Plc is higher than it is for about just 6.24% of US stocks.
  • With a year-over-year growth in debt of -80.55%, Amarin Corp Plc's debt growth rate surpasses merely 3.16% of about US stocks.
  • Stocks that are quantitatively similar to AMRN, based on their financial statements, market capitalization, and price volatility, are JJSF, FMX, BCOR, SU, and NVCR.
  • Visit AMRN's SEC page to see the company's official filings. To visit the company's web site, go to www.amarincorp.com.

AMRN Valuation Summary

  • AMRN's EV/EBIT ratio is 162.7; this is 509.36% higher than that of the median Healthcare stock.
  • AMRN's price/sales ratio has moved NA NA over the prior 129 months.
  • AMRN's price/sales ratio has moved NA NA over the prior 129 months.

Below are key valuation metrics over time for AMRN.

Stock Date P/S P/B P/E EV/EBIT
AMRN 2020-10-19 3.6 3.2 -156.0 -170.6
AMRN 2015-02-23 5.2 -3.6 -4.8 -12.3
AMRN 2014-07-14 7.9 -4.8 -2.1 -3.6
AMRN 2013-05-23 445.4 -17.4 -6.8 -8.7
AMRN 2012-08-08 NA 317.2 -61.4 -98.4
AMRN 2011-11-11 NA -32.0 -3.9 -3.4

AMRN Growth Metrics

  • The 5 year revenue growth rate now stands at 614.31%.
  • Its year over year cash and equivalents growth rate is now at -11.43%.
  • Its 4 year revenue growth rate is now at 459.8%.
Over the past 30 months, AMRN's revenue has gone up $395,486,000.

The table below shows AMRN's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-03-31 601.237 -44.587 0.927
2020-12-31 614.06 -21.746 -18
2020-09-30 590.086 7.641 -15.858
2020-06-30 545.995 18.538 -12.532
2020-03-31 511.47 32.86 -18.767
2019-12-31 429.755 -9.366 -22.645

AMRN Stock Price Chart Interactive Chart >

Price chart for AMRN

AMRN Price/Volume Stats

Current price $4.14 52-week high $9.25
Prev. close $4.24 52-week low $3.36
Day low $4.13 Volume 1,772,500
Day high $4.25 Avg. volume 5,177,250
50-day MA $4.49 Dividend yield N/A
200-day MA $5.36 Market Cap 1.63B

Amarin Corp. PLC ADR (AMRN) Company Bio


Amarin Corporation plc, a biopharmaceutical company, focuses on developing and commercializing therapeutics for the treatment of cardiovascular diseases in the United States. The company was founded in 1989 and is based in Dublin, Ireland.


AMRN Latest News Stream


Event/Time News Detail
Loading, please wait...

AMRN Latest Social Stream


Loading social stream, please wait...

View Full AMRN Social Stream

Latest AMRN News From Around the Web

Below are the latest news stories about Amarin Corp Plc that investors may wish to consider to help them evaluate AMRN as an investment opportunity.

7 Reddit Penny Stocks About to Explode

With Reddit's regular targets finally dropping, these stocks could be the next target for another crazy wave of Reddit Penny Stocks.

Chris Lau on InvestorPlace | July 19, 2021

Is Amarin Corporation plc (AMRN) Going to Burn These Hedge Funds?

How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of […]

Yahoo | July 19, 2021

Amarin to Report Second Quarter and Six Month 2021 Financial Results and Host Conference Call on August 5, 2021

DUBLIN, Ireland and BRIDGEWATER, N.J., July 15, 2021 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with members of Amarin senior management to discuss the company's second quarter and six month 2021 financial results and provide an operational update on Thursday, August 5, 2021, at 7:30 a.m. ET. The conference call will follow the anticipated release of the company's financial results earlier that day. Conference Call and Webcast Inf

Yahoo | July 15, 2021

Amarin: Let's Revisit The M&A Discussion

chaofann/iStock via Getty ImagesWhen it comes to M&A, as was pointed out in this article, mature firms do not like great uncertainties driven by litigation and questions of market share risks, which is exactly where Amarin (AMRN) finds itself in the US. Just so we are clear, here is a...

StrategyDoc on Seeking Alpha | July 9, 2021

Why Amarin Fell Again Today

Another Vascepa generic is launched in the U.S.

The Motley Fool | June 22, 2021

Read More 'AMRN' Stories Here

AMRN Price Returns

1-mo -5.69%
3-mo -16.70%
6-mo -49.51%
1-year -36.11%
3-year 52.77%
5-year 30.19%
YTD -15.34%
2020 -77.19%
2019 57.53%
2018 239.40%
2017 30.19%
2016 62.96%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8093 seconds.